Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1990 Mar;28(3):525–529. doi: 10.1128/jcm.28.3.525-529.1990

Novel gelatin particle agglutination test for serodiagnosis of leprosy in the field.

S Izumi 1, T Fujiwara 1, M Ikeda 1, Y Nishimura 1, K Sugiyama 1, K Kawatsu 1
PMCID: PMC269656  PMID: 2182670

Abstract

We developed a novel gelatin particle agglutination test (MLPA) for the serodiagnosis of leprosy; this test is especially useful for clinical practice and epidemiological surveys of leprosy in countries in which the disease is endemic. The antigen used in the test is the chemically synthesized trisaccharide moiety of Mycobacterium leprae-specific phenolic glycolipid I. MLPA is a simple and easy technique having sensitivity and specificity comparable to those of the conventional indirect enzyme-linked immunosorbent assay. The new technique was found to be useful for monitoring of chemotherapy and predictive diagnosis of high-risk individuals in contact with persons with leprosy and may be useful for the prediction of relapse. We are now preparing to supply a quality-controlled ready-to-use MLPA kit for leprosy control in countries in which leprosy is endemic.

Full text

PDF
525

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Agis F., Schlich P., Cartel J. L., Guidi C., Bach M. A. Use of anti-M. leprae phenolic glycolipid-I antibody detection for early diagnosis and prognosis of leprosy. Int J Lepr Other Mycobact Dis. 1988 Dec;56(4):527–535. [PubMed] [Google Scholar]
  2. Aguado Sanchez G., Malik A., Tougne C., Lambert P. H., Engers H. D. Simplification and standardization of serodiagnostic tests for leprosy based on phenolic glycolipid-I (PG-I) antigen. Lepr Rev. 1986 Dec;57 (Suppl 2):83–93. doi: 10.5935/0305-7518.19860058. [DOI] [PubMed] [Google Scholar]
  3. Bach M. A., Wallach D., Flageul B., Hoffenbach A., Cottenot F. Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy. Int J Lepr Other Mycobact Dis. 1986 Jun;54(2):256–267. [PubMed] [Google Scholar]
  4. Baumgart K., Britton W., Basten A., Bagshawe A. Use of phenolic glycolipid 1 for serodiagnosis of leprosy in a high prevalence village in Papua New Guinea. Trans R Soc Trop Med Hyg. 1987;81(6):1030–1032. doi: 10.1016/0035-9203(87)90388-9. [DOI] [PubMed] [Google Scholar]
  5. Brennan P. J., Barrow W. W. Evidence for species-specific lipid antigens in Mycobacterium leprae. Int J Lepr Other Mycobact Dis. 1980 Dec;48(4):382–387. [PubMed] [Google Scholar]
  6. Brett S. J., Draper P., Payne S. N., Rees R. J. Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis. Clin Exp Immunol. 1983 May;52(2):271–279. [PMC free article] [PubMed] [Google Scholar]
  7. Brett S. J., Payne S. N., Gigg J., Burgess P., Gigg R. Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid I in the serology of leprosy. Clin Exp Immunol. 1986 Jun;64(3):476–483. [PMC free article] [PubMed] [Google Scholar]
  8. Britton W. J., Garsia R. J., Basten A. The serological response to the phenolic glycolipid of Mycobacterium leprae in Australian and Nepali leprosy patients. Aust N Z J Med. 1987 Dec;17(6):568–573. doi: 10.1111/j.1445-5994.1987.tb01257.x. [DOI] [PubMed] [Google Scholar]
  9. Buchanan T. M., Young D. B., Miller R. A., Khanolkar S. R. Serodiagnosis of infection with Mycobacterium leprae. Int J Lepr Other Mycobact Dis. 1983 Dec;51(4):524–530. [PubMed] [Google Scholar]
  10. Chanteau S., Cartel J. L., Guidi C., Plichart R., Bach M. A. Seroepidemiological study on 724 household contacts of leprosy patients in French Polynesia using disaccharide-octyl-BSA as antigen. Int J Lepr Other Mycobact Dis. 1987 Dec;55(4):626–632. [PubMed] [Google Scholar]
  11. Chanteau S., Cartel J. L., Roux J., Plichart R., Bach M. A. Comparison of synthetic antigens for detecting antibodies to phenolic glycolipid I in patients with leprosy and their household contacts. J Infect Dis. 1988 Apr;157(4):770–776. doi: 10.1093/infdis/157.4.770. [DOI] [PubMed] [Google Scholar]
  12. Chatterjee D., Cho S. N., Brennan P. J., Aspinall G. O. Chemical synthesis and seroreactivity of O-(3,6-di-O-methyl-beta-D-glucopyranosyl)-(1----4)-O-(2,3-di-O-methyl- alpha-L-rhamnopyranosyl)-(1----9)-oxynonanoyl-bovine serum albumin--the leprosy-specific, natural disaccharide-octyl-neoglycoprotein. Carbohydr Res. 1986 Nov 15;156:39–56. doi: 10.1016/s0008-6215(00)90098-3. [DOI] [PubMed] [Google Scholar]
  13. Cho S. N., Chatterjee D., Brennan P. J. A simplified serological test for leprosy based on a 3,6-di-O-methylglucose-containing synthetic antigen. Am J Trop Med Hyg. 1986 Jan;35(1):167–172. doi: 10.4269/ajtmh.1986.35.167. [DOI] [PubMed] [Google Scholar]
  14. Cho S. N., Hunter S. W., Gelber R. H., Rea T. H., Brennan P. J. Quantitation of the phenolic glycolipid of Mycobacterium leprae and relevance to glycolipid antigenemia in leprosy. J Infect Dis. 1986 Mar;153(3):560–569. doi: 10.1093/infdis/153.3.560. [DOI] [PubMed] [Google Scholar]
  15. Cho S. N., Yanagihara D. L., Hunter S. W., Gelber R. H., Brennan P. J. Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy. Infect Immun. 1983 Sep;41(3):1077–1083. doi: 10.1128/iai.41.3.1077-1083.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Douglas J. T., Celona R. V., Abalos R. M., Madarang M. G., Fajardo T. Serological reactivity and early detection of leprosy among contacts of lepromatous patients in Cebu, the Philippines. Int J Lepr Other Mycobact Dis. 1987 Dec;55(4):718–721. [PubMed] [Google Scholar]
  17. Douglas J. T., Hirsch D. S., Fajardo T. T., Cellona R. V., Abalos R. M., de la Cruz E. C., Madarang M. G., de Wit M. Y., Klatser P. R. Evaluation of Mycobacterium leprae antigens in the serological monitoring of a clofazimine-based chemotherapeutic study of dapsone resistant lepromatous leprosy patients in Cebu, Philippines. Lepr Rev. 1989 Mar;60(1):8–19. doi: 10.5935/0305-7518.19890002. [DOI] [PubMed] [Google Scholar]
  18. Douglas J. T. Progress in the serology of leprosy at the University of Hawaii. Hawaii Med J. 1988 Feb;47(2):62–65. [PubMed] [Google Scholar]
  19. Douglas J. T., Steven L. M., Fajardo T., Cellona R. V., Madarang M. G., Abalos R. M., Steenbergen G. J. The effects of chemotherapy on antibody levels in lepromatous patients. Lepr Rev. 1988 Jun;59(2):127–135. doi: 10.5935/0305-7518.19880017. [DOI] [PubMed] [Google Scholar]
  20. Fujiwara T., Hunter S. W., Cho S. N., Aspinall G. O., Brennan P. J. Chemical synthesis and serology of disaccharides and trisaccharides of phenolic glycolipid antigens from the leprosy bacillus and preparation of a disaccharide protein conjugate for serodiagnosis of leprosy. Infect Immun. 1984 Jan;43(1):245–252. doi: 10.1128/iai.43.1.245-252.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gaylord H., Brennan P. J. Leprosy and the leprosy bacillus: recent developments in characterization of antigens and immunology of the disease. Annu Rev Microbiol. 1987;41:645–675. doi: 10.1146/annurev.mi.41.100187.003241. [DOI] [PubMed] [Google Scholar]
  22. Hunter S. W., Fujiwara T., Brennan P. J. Structure and antigenicity of the major specific glycolipid antigen of Mycobacterium leprae. J Biol Chem. 1982 Dec 25;257(24):15072–15078. [PubMed] [Google Scholar]
  23. Lemieux R. U., Bundle D. R., Baker D. A. The properties of a "synthetic" antigen related to the human blood-group Lewis a. J Am Chem Soc. 1975 Jul 9;97(14):4076–4083. doi: 10.1021/ja00847a035. [DOI] [PubMed] [Google Scholar]
  24. Lyons N. F., Shannon E. J., Ellis B. P., Naafs B. Association of IgG and IgM antibodies to phenolic glycolipid-1 antigen of Mycobacterium leprae with disease parameters in multibacillary leprosy patients. Lepr Rev. 1988 Mar;59(1):45–52. doi: 10.5935/0305-7518.19880008. [DOI] [PubMed] [Google Scholar]
  25. Menzel S., Harboe M., Bergsvik H., Brennan P. J. Antibodies to a synthetic analog of phenolic glycolipid-I of Mycobacterium leprae in healthy household contacts of patients with leprosy. Int J Lepr Other Mycobact Dis. 1987 Dec;55(4):617–625. [PubMed] [Google Scholar]
  26. Miller R. A., Gorder D., Harnisch J. P. Antibodies to phenolic glycolipid-I during long-term therapy: serial measurements in individual patients. Int J Lepr Other Mycobact Dis. 1987 Dec;55(4):633–636. [PubMed] [Google Scholar]
  27. Petchclai B., Khupulsup K., Hiranras S., Sampatavanich S., Sampoonachot P., Leelarusamee A. A passive hemagglutination test for leprosy using a synthetic disaccharide antigen. Int J Lepr Other Mycobact Dis. 1988 Jun;56(2):255–258. [PubMed] [Google Scholar]
  28. Young D. B., Buchanan T. M. A serological test for leprosy with a glycolipid specific for Mycobacterium leprae. Science. 1983 Sep 9;221(4615):1057–1059. doi: 10.1126/science.6348948. [DOI] [PubMed] [Google Scholar]
  29. Young D. B., Dissanayake S., Miller R. A., Khanolkar S. R., Buchanan T. M. Humans respond predominantly with IgM immunoglobulin to the species-specific glycolipid of Mycobacterium leprae. J Infect Dis. 1984 Jun;149(6):870–873. doi: 10.1093/infdis/149.6.870. [DOI] [PubMed] [Google Scholar]
  30. Young D. B., Fohn M. J., Khanolkar S. R., Buchanan T. M. A spot test for detection of antibodies to phenolic glycolipid I. Lepr Rev. 1985 Sep;56(3):193–198. doi: 10.5935/0305-7518.19850021. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES